Cargando…

CD19( (+)) CD56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia

Patients diagnosed with severe aplastic anaemia and without a compatible bone marrow transplant donor are treated with immunosuppressive therapy. These patients are found with time to develop a clonal disease such as myelodysplasia or paroxysmal nocturnal haemoglobinuria. However, the development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Nigel P, Ruiz, M Amparo, Miranda, G Maximiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336392/
https://www.ncbi.nlm.nih.gov/pubmed/28275389
http://dx.doi.org/10.3332/ecancer.2017.720
_version_ 1782512206160592896
author Murray, Nigel P
Ruiz, M Amparo
Miranda, G Maximiliano
author_facet Murray, Nigel P
Ruiz, M Amparo
Miranda, G Maximiliano
author_sort Murray, Nigel P
collection PubMed
description Patients diagnosed with severe aplastic anaemia and without a compatible bone marrow transplant donor are treated with immunosuppressive therapy. These patients are found with time to develop a clonal disease such as myelodysplasia or paroxysmal nocturnal haemoglobinuria. However, the development of plasma cell dyscrasias is rare. We report the case here of a patient treated with immunosuppressive therapy who went on to develop myeloma 11 months after being diagnosed with severe aplastic anaemia. We include here a review of the literature.
format Online
Article
Text
id pubmed-5336392
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-53363922017-03-08 CD19( (+)) CD56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia Murray, Nigel P Ruiz, M Amparo Miranda, G Maximiliano Ecancermedicalscience Case Report Patients diagnosed with severe aplastic anaemia and without a compatible bone marrow transplant donor are treated with immunosuppressive therapy. These patients are found with time to develop a clonal disease such as myelodysplasia or paroxysmal nocturnal haemoglobinuria. However, the development of plasma cell dyscrasias is rare. We report the case here of a patient treated with immunosuppressive therapy who went on to develop myeloma 11 months after being diagnosed with severe aplastic anaemia. We include here a review of the literature. Cancer Intelligence 2017-02-14 /pmc/articles/PMC5336392/ /pubmed/28275389 http://dx.doi.org/10.3332/ecancer.2017.720 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Murray, Nigel P
Ruiz, M Amparo
Miranda, G Maximiliano
CD19( (+)) CD56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia
title CD19( (+)) CD56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia
title_full CD19( (+)) CD56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia
title_fullStr CD19( (+)) CD56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia
title_full_unstemmed CD19( (+)) CD56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia
title_short CD19( (+)) CD56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia
title_sort cd19( (+)) cd56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336392/
https://www.ncbi.nlm.nih.gov/pubmed/28275389
http://dx.doi.org/10.3332/ecancer.2017.720
work_keys_str_mv AT murraynigelp cd19cd56myelomaarisinginapatientwhofailedtwocoursesofimmunosupressivetherapyforaplasticanaemia
AT ruizmamparo cd19cd56myelomaarisinginapatientwhofailedtwocoursesofimmunosupressivetherapyforaplasticanaemia
AT mirandagmaximiliano cd19cd56myelomaarisinginapatientwhofailedtwocoursesofimmunosupressivetherapyforaplasticanaemia